votubia 2mg dispersible tablets
novartis pharmaceuticals uk ltd - everolimus - dispersible tablet - 2mg
votubia 3mg dispersible tablets
novartis pharmaceuticals uk ltd - everolimus - dispersible tablet - 3mg
votubia 5mg dispersible tablets
novartis pharmaceuticals uk ltd - everolimus - dispersible tablet - 5mg
kisqali 200mg tablets
novartis pharmaceuticals uk ltd - ribociclib succinate - tablet - 200mg
cosentyx 150mg1ml solution for injection pre-filled syringes
novartis pharmaceuticals uk ltd - secukinumab - solution for injection - 150mg/1ml
ilaris 150mg1ml solution for injection vials
novartis pharmaceuticals uk ltd - canakinumab - solution for injection - 150mg/1ml
rydapt 25mg capsules
novartis pharmaceuticals uk ltd - midostaurin - capsule - 25mg
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,
galvus met 50/850mg film-coated tablet
novartis corporation (malaysia) sdn. bhd. - metformin hydrochloride; vildagliptin -
galvus met 50/500mg film-coated tablet
novartis corporation (malaysia) sdn. bhd. - metformin hydrochloride; vildagliptin -